Weekly News Roundup – Immunology, Innovation, and Impact
Update: 2025-10-10
Description
This week’s tHEORetically Speaking News Roundup covers nirsevimab’s real-world success in reducing RSV hospitalizations among infants, Boehringer Ingelheim’s FDA approval of Jascayd for idiopathic pulmonary fibrosis, and Arthrosi Therapeutics’ $153 million raise to advance a next-generation gout drug. We also highlight this year’s Nobel Prize in Medicine, honoring discoveries in immune tolerance that continue to shape today’s biggest breakthroughs.
Tune in for this concise recap of these pivotal industry updates!
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
